EMERY DARYLL A.,STRAUB DARREN E.,WONDERLING LAURA,HERRON OLSON LISA L.
申请号：
NZ61392306
公开号：
NZ613923A
申请日:
2006.02.14
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
613923 Disclosed is the use of a composition in the preparation of a medicament for treating an infection in a subject caused by a Staphylococcus spp, or for treating a subject at risk of having an infection caused by a Staphylococcus spp., wherein the composition comprises: a combination of antibodies that specifically binds to at least five polypeptides having molecular weights of 88 kDa, 55 kDa, 38 kDa, 37 kDa, 36 kDa, 35 kDa, or 33 kDa, wherein molecular weight is determined by electrophoresis on a sodium dodecyl sulfate-polyacrylamide gel, wherein the polypeptides are isolatable from a Staphylococcus aureus when incubated in media comprising an iron chelator and not isolatable when grown in the media without the iron chelator, and wherein the composition protects an animal against challenge with S. aureus ATCC strain 19636.
